Jeff Sessions Just Said He Supports Marijuana Research But Is It All for Show?

Attorney General Jeff Sessions is no fan of marijuana. On many occasions, he's said he wants to use Department of Justice resources to crackdown on the marijuana industry in legal states (even though that is currently not allowed). But it turns out there is one area where Session supports marijuana: research.

Sessions appeared in front of a Senate Committee yesterday to discuss a proposal made by Sen. Orrin Hatch to increase research of marijuana by the federal government. As part of Hatch's proposal, 26 different companies have applied to supply the Drug Enforcement Agency with cannabis to test. And believe it or not, Session actually approves and wants to increase the study of marijuana!

The Attorney General said he still wants the process to be supervised heavily by the DEA, and he doesn't think the federal government needs 26 different companies growing marijuana for them.

"I think it would be healthy to have some more competition in the supply but I’m sure we don’t need 26 new suppliers," Sessions said. "Each one of those has to be supervised by the DEA, and I have raised questions about how many and let’s be sure we’re doing this in the right way because it costs a lot of money to supervise these."

Of course, the reason Sessions probably supports marijuana research is because he thinks the DEA will find evidence that cannabis is poisoning our brains or some other ridiculous belief he has about the drug. So it shouldn't be seen as that radical a move by the Attorney General.

Even Hatch, the senator who proposed increased research, has said he doesn't support legalization and only thinks the federal government should have a better understanding of the drug.

So instead of Jeff Sessions being 100 percent unreasonable when it comes to marijuana, he may only be 99 percent.

(h/t Business Insider)


Though it can be hard to follow the the roller coaster ride that is keeping up with the cannabis stock market, Thomas George of Grizzle breaks it down for us simply and clearly. In the latest episode of All Time Highs, we get the lowdown on Aurora, one of the most expensive cannabis stocks, an update on Canopy's earnings, and intel on Aphria's past fraud allegations. Now in the clear, it may only be a matter of time before Aphria catches up.

Can we see some ID please?

You must be 19 years of age or older to enter.